SF-1 expression during adrenal development and tumourigenesis

Molecular and Cellular Endocrinology

Volumn 351, Issue 1, 2012, Pages 12-18

  Gardiner, Jennifer R ^a   Shima, Yuichi ^b   Morohashi, Ken ichirou ^b   Swain, Amanda ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Adrenal; Cancer; Steroidogenic factor 1; Transcriptional regulation

Indexed keywords

STEROIDOGENIC FACTOR 1;

ADRENAL CANCER; ADRENAL CORTEX DEVELOPMENT; ADRENAL CORTEX TUMOR; CANCER PROGNOSIS; CARCINOGENESIS; CHILDHOOD CANCER; CONGENITAL ADRENAL HYPERPLASIA; CYP11A1 GENE; ENHANCER REGION; FETUS DEVELOPMENT; GENE; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; HUMAN; INTRON; MARKER GENE; NONHUMAN; ORGANOGENESIS; POD1 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SF 1 GENE; TESTICULAR ADRENAL RESTS TUMOR; TESTIS TUMOR; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; INTRONS; NEOPLASM PROTEINS; STEROIDOGENIC FACTOR 1;

EID: 84857108757     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.10.007     Document Type: Review

References (74)

1. Achermann J.C., Ito M., Hindmarsh P.C., Jameson J.L. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat. Genet. 1999, 22:125-126.
2. Aesoy R., Mellgren G., Morohashi K., Lund J. Activation of cAMP-dependent protein kinase increases the protein level of steroidogenic factor-1. Endocrinology 2002, 143:295-303.
3. Ahtiainen P., Rulli S.B., Shariatmadari R., Pelliniemi L.J., Toppari J., Poutanen M., Huhtaniemi I.T. Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level: a study on hCG overexpressing transgenic mice. Oncogene 2005, 24:7301-7309.
4. Almeida M.Q., Soares I.C., Ribeiro T.C., Fragoso M.C., Marins L.V., Wakamatsu A., Ressio R.A., Nishi M.Y., Jorge A.A., Lerario A.M., Alves V.A., Mendonca B.B., Latronico A.C. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. J. Clin. Endocrinol. Metab. 2010, 95:1458-1462.
5. Babu P.S., Bavers D.L., Beuschlein F., Shah S., Jeffs B., Jameson J.L., Hammer G.D. Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology 2002, 143:665-673.
6. Bamforth S.D., Braganca J., Eloranta J.J., Murdoch J.N., Marques F.I., Kranc K.R., Farza H., Henderson D.J., Hurst H.C., Bhattacharya S. Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat. Genet. 2001, 29:469-474.
7. Beuschlein F., Mutch C., Bavers D.L., Ulrich-Lai Y.M., Engeland W.C., Keegan C., Hammer G.D. Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 2002, 143:3122-3135.
8. Bhattacharya S., Michels C.L., Leung M.K., Arany Z.P., Kung A.L., Livingston D.M. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 1999, 13:64-75.
9. Bland M.L., Fowkes R.C., Ingraham H.A. Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function. Mol. Endocrinol. 2004, 18:941-952.
10. Bland M.L., Jamieson C.A., Akana S.F., Bornstein S.R., Eisenhofer G., Dallman M.F., Ingraham H.A. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc. Natl. Acad. Sci. USA 2000, 97:14488-14493.
11. Buaas F.W., Val P., Swain A. The transcription co-factor CITED2 functions during sex determination and early gonad development. Hum. Mol. Genet. 2009, 18:2989-3001.
12. Buckler A.J., Pelletier J., Haber D.A., Glaser T., Housman D.E. Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol. Cell. Biol. 1991, 11:1707-1712.
13. Cabrera M.S., Vogiatzi M.G., New M.I. Long term outcome in adult males with classic congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 2001, 86:3070-3078.
14. Call K.M., Glaser T., Ito C.Y., Buckler A.J., Pelletier J., Haber D.A., Rose E.A., Kral A., Yeger H., Lewis W.H., et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990, 60:509-520.
15. Chen W.Y., Juan L.J., Chung B.C. SF-1 (nuclear receptor 5A1) activity is activated by cyclic AMP via p300-mediated recruitment to active foci, acetylation, and increased DNA binding. Mol. Cell. Biol. 2005, 25:10442-10453.
16. Chou Y.T., Wang H., Chen Y., Danielpour D., Yang Y.C. Cited2 modulates TGF-beta-mediated upregulation of MMP9. Oncogene 2006, 25:5547-5560.
17. Claahsen-van der Grinten H.L., Hermus A.R., Otten B.J. Testicular adrenal rest tumours in congenital adrenal hyperplasia. Int. J. Pediatr. Endocrinol. 2009, 2009:624823.
18. Clark R.V., Albertson B.D., Munabi A., Cassorla F., Aguilera G., Warren D.W., Sherins R.J., Loriaux D.L. Steroidogenic enzyme activities, morphology, and receptor studies of a testicular adrenal rest in a patient with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 1990, 70:1408-1413.
19. Cui S., Ross A., Stallings N., Parker K.L., Capel B., Quaggin S.E. Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice. Development 2004, 131:4095-4105.
20. Daggett M.A., Rice D.A., Heckert L.L. Expression of steroidogenic factor 1 in the testis requires an E box and CCAAT box in its promoter proximal region. Biol. Reprod. 2000, 62:670-679.
21. Doghman M., Karpova T., Rodrigues G.A., Arhatte M., De Moura J., Cavalli L.R., Virolle V., Barbry P., Zambetti G.P., Figueiredo B.C., Heckert L.L., Lalli E. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol. Endocrinol. 2007, 21:2968-2987.
22. Fatchiyah Zubair M., Shima Y., Oka S., Ishihara S., Fukui-Katoh Y., Morohashi K. Differential gene dosage effects of Ad4BP/SF-1 on target tissue development. Biochem. Biophys. Res. Commun. 2006, 341:1036-1045.
23. Ferraz-de-Souza B., Lin L., Achermann J.C. Steroidogenic factor-1 (SF-1, NR5A1) and human disease. Mol. Cell. Endocrinol. 2011, 336:198-205.
24. Figueiredo B.C., Cavalli L.R., Pianovski M.A., Lalli E., Sandrini R., Ribeiro R.C., Zambetti G., DeLacerda L., Rodrigues G.A., Haddad B.R. Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J. Clin. Endocrinol. Metab. 2005, 90:615-619.
25. Figueiredo B.C., Stratakis C.A., Sandrini R., DeLacerda L., Pianovsky M.A., Giatzakis C., Young H.M., Haddad B.R. Comparative genomic hybridization analysis of adrenocortical tumors of childhood. J. Clin. Endocrinol. Metab. 1999, 84:1116-1121.
26. Hammes A., Guo J.K., Lutsch G., Leheste J.R., Landrock D., Ziegler U., Gubler M.C., Schedl A. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 2001, 106:319-329.
27. Harris A.N., Mellon P.L. The basic helix-loop-helix, leucine zipper transcription factor, USF (upstream stimulatory factor), is a key regulator of SF-1 (steroidogenic factor-1) gene expression in pituitary gonadotrope and steroidogenic cells. Mol. Endocrinol. 1998, 12:714-726.
28. Hasegawa T., Fukami M., Sato N., Katsumata N., Sasaki G., Fukutani K., Morohashi K., Ogata T. Testicular dysgenesis without adrenal insufficiency in a 46, XY patient with a heterozygous inactive mutation of steroidogenic factor-1. J. Clin. Endocrinol. Metab. 2004, 89:5930-5935.
29. Hastie N.D. Life, sex, and WT1 isoforms-three amino acids can make all the difference. Cell 2001, 106:391-394.
30. Hatano O., Takakusu A., Nomura M., Morohashi K. Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1. Genes Cells 1996, 1:663-671.
31. Hoivik E.A., Aumo L., Aesoy R., Lillefosse H., Lewis A.E., Perrett R.M., Stallings N.R., Hanley N.A., Bakke M. Deoxyribonucleic acid methylation controls cell type-specific expression of steroidogenic factor 1. Endocrinology 2008, 149:5599-5609.
32. Hoivik E.A., Bjanesoy T.E., Mai O., Okamoto S., Minokoshi Y., Shima Y., Morohashi K., Boehm U., Bakke M. DNA methylation of intronic enhancers directs tissue-specific expression of steroidogenic factor 1/adrenal 4 binding protein (SF-1/Ad4BP). Endocrinology 2011, 152:2100-2112.
33. Ikeda Y., Shen W.H., Ingraham H.A., Parker K.L. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol. Endocrinol. 1994, 8:654-662.
34. Ishihara S.L., Morohashi K. A boundary for histone acetylation allows distinct expression patterns of the Ad4BP/SF-1 and GCNF loci in adrenal cortex cells. Biochem. Biophys. Res. Commun. 2005, 329:554-562.
35. Jacob A.L., Lund J., Martinez P., Hedin L. Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5. J. Biol. Chem. 2001, 276:37659-37664.
36. James L.A., Kelsey A.M., Birch J.M., Varley J.M. Highly consistent genetic alterations in childhood adrenocortical tumours detected by comparative genomic hybridization. Br. J. Cancer 1999, 81:300-304.
37. Kaneko T., Kojima Y., Umemoto Y., Sasaki S., Hayashi Y., Kohri K. Usefulness of transcription factors Ad4BP/SF-1 and DAX-1 as immunohistologic markers for diagnosis of advanced adrenocortical carcinoma. Horm. Res. 2008, 70:294-299.
38. Karpova T., Presley J., Manimaran R.R., Scherrer S.P., Tejada L., Peterson K.R., Heckert L.L. A FTZ-F1-containing yeast artificial chromosome recapitulates expression of steroidogenic factor 1 in vivo. Mol. Endocrinol. 2005, 19:2549-2563.
39. Katoh-Fukui Y., Owaki A., Toyama Y., Kusaka M., Shinohara Y., Maekawa M., Toshimori K., Morohashi K. Mouse polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression. Blood 2005, 106:1612-1620.
40. Komatsu T., Mizusaki H., Mukai T., Ogawa H., Baba D., Shirakawa M., Hatakeyama S., Nakayama K.I., Yamamoto H., Kikuchi A., Morohashi K. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. Mol. Endocrinol. 2004, 18:2451-2462.
41. Lalli E. Adrenocortical development and cancer: focus on SF-1. J. Mol. Endocrinol. 2010, 44:301-307.
42. Lee F.Y., Faivre E.J., Suzawa M., Lontok E., Ebert D., Cai F., Belsham D.D., Ingraham H.A. Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine development. Dev. Cell. 2011, 21:315-327.
43. Lee M.B., Lebedeva L.A., Suzawa M., Wadekar S.A., Desclozeaux M., Ingraham H.A. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification. Mol. Cell. Biol. 2005, 25:1879-1890.
44. Lopez D., Nackley A.C., Shea-Eaton W., Xue J., Schimmer B.P., McLean M.P. Effects of mutating different steroidogenic factor-1 protein regions on gene regulation. Endocrine 2001, 14:353-362.
45. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-490.
46. Mallet D., Bretones P., Michel-Calemard L., Dijoud F., David M., Morel Y. Gonadal dysgenesis without adrenal insufficiency in a 46, XY patient heterozygous for the nonsense C16X mutation: a case of SF1 haploinsufficiency. J. Clin. Endocrinol. Metab. 2004, 89:4829-4832.
47. Marques-Pereira R., Delacerda L., Lacerda H.M., Michalkiewicz E., Sandrini F., Sandrini R. Childhood adrenocortical tumours: a review. Hered. Cancer Clin. Pract. 2006, 4:81-89.
48. Martinez-Arguelles D.B., Papadopoulos V. Epigenetic regulation of the expression of genes involved in steroid hormone biosynthesis and action. Steroids 2010, 75:467-476.
49. Morohashi K., Honda S., Inomata Y., Handa H., Omura T. A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. J. Biol. Chem. 1992, 267:17913-17919.
50. Nomura M., Bartsch S., Nawata H., Omura T., Morohashi K. An E box element is required for the expression of the ad4bp gene, a mammalian homologue of ftz-f1 gene, which is essential for adrenal and gonadal development. J. Biol. Chem. 1995, 270:7453-7461.
51. Nomura M., Nawata H., Morohashi K. Autoregulatory loop in the regulation of the mammalian ftz-f1 gene. J. Biol. Chem. 1996, 271:8243-8249.
52. Oberman A.S., Flatau E., Luboshitzky R. Bilateral testicular adrenal rests in a patient with 11-hydroxylase deficient congenital adrenal hyperplasia. J. Urol. 1993, 149:350-352.
53. Pianovski M.A., Cavalli L.R., Figueiredo B.C., Santos S.C., Doghman M., Ribeiro R.C., Oliveira A.G., Michalkiewicz E., Rodrigues G.A., Zambetti G., Haddad B.R., Lalli E. SF-1 overexpression in childhood adrenocortical tumours. Eur. J. Cancer 2006, 42:1040-1043.
54. Sadovsky Y., Crawford P.A., Woodson K.G., Polish J.A., Clements M.A., Tourtellotte L.M., Simburger K., Milbrandt J. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. USA 1995, 92:10939-10943.
55. Sasano H., Shizawa S., Nagura H. Adrenocortical cytopathology. Am. J. Clin. Pathol. 1995, 104:161-166.
56. Sasano H., Shizawa S., Suzuki T., Takayama K., Fukaya T., Morohashi K., Nagura H. Ad4BP in the human adrenal cortex and its disorders. J. Clin. Endocrinol. Metab. 1995, 80:2378-2380.
57. Sasano H., Shizawa S., Suzuki T., Takayama K., Fukaya T., Morohashi K., Nagura H. Transcription factor adrenal 4 binding protein as a marker of adrenocortical malignancy. Hum. Pathol. 1995, 26:1154-1156.
58. Sbiera S., Schmull S., Assie G., Voelker H.U., Kraus L., Beyer M., Ragazzon B., Beuschlein F., Willenberg H.S., Hahner S., Saeger W., Bertherat J., Allolio B., Fassnacht M. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. J. Clin. Endocrinol. Metab. 2010, 95:E161-E171.
59. Schimmer B.P., White P.C. Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. Mol. Endocrinol. 2010, 24:1322-1337.
60. Schnabel C.A., Selleri L., Cleary M.L. Pbx1 is essential for adrenal development and urogenital differentiation. Genesis 2003, 37:123-130.
61. Shima Y., Zubair M., Ishihara S., Shinohara Y., Oka S., Kimura S., Okamoto S., Minokoshi Y., Suita S., Morohashi K. Ventromedial hypothalamic nucleus-specific enhancer of Ad4BP/SF-1 gene. Mol. Endocrinol. 2005, 19:2812-2823.
62. Shima Y., Zubair M., Komatsu T., Oka S., Yokoyama C., Tachibana T., Hjalt T.A., Drouin J., Morohashi K. Pituitary homeobox 2 regulates adrenal4 binding protein/steroidogenic factor-1 gene transcription in the pituitary gonadotrope through interaction with the intronic enhancer. Mol. Endocrinol. 2008, 22:1633-1646.
63. Stallings N.R., Hanley N.A., Majdic G., Zhao L., Bakke M., Parker K.L. Development of a transgenic green fluorescent protein lineage marker for steroidogenic factor 1. Mol. Endocrinol. 2002, 16:2360-2370.
64. Val P., Jeays-Ward K., Swain A. Identification of a novel population of adrenal-like cells in the mammalian testis. Dev. Biol. 2006, 299:250-256.
65. Val P., Martinez-Barbera J.P., Swain A. Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage. Development 2007, 134:2349-2358.
66. Val P., Swain A. Gene dosage effects and transcriptional regulation of early mammalian adrenal cortex development. Mol. Cell. Endocrinol. 2010, 323:105-114.
67. Wilhelm D., Englert C. The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev. 2002, 16:1839-1851.
68. Wilkin F., Gagne N., Paquette J., Oligny L.L., Deal C. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression. J. Clin. Endocrinol. Metab. 2000, 85:2048-2056.
69. Woodson K.G., Crawford P.A., Sadovsky Y., Milbrandt J. Characterization of the promoter of SF-1, an orphan nuclear receptor required for adrenal and gonadal development. Mol. Endocrinol. 1997, 11:117-126.
70. Xue Q., Lin Z., Yin P., Milad M.P., Cheng Y.H., Confino E., Reierstad S., Bulun S.E. Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5' CpG island in endometriosis. J. Clin. Endocrinol. Metab. 2007, 92:3261-3267.
71. Yang W.H., Heaton J.H., Brevig H., Mukherjee S., Iniguez-Lluhi J.A., Hammer G.D. SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation. Mol. Cell. Biol. 2009, 29:613-625.
72. Zubair M., Ishihara S., Oka S., Okumura K., Morohashi K. Two-step regulation of Ad4BP/SF-1 gene transcription during fetal adrenal development: initiation by a Hox-Pbx1-Prep1 complex and maintenance via autoregulation by Ad4BP/SF-1. Mol. Cell. Biol. 2006, 26:4111-4121.
73. Zubair M., Oka S., Parker K.L., Morohashi K. Transgenic expression of Ad4BP/SF-1 in fetal adrenal progenitor cells leads to ectopic adrenal formation. Mol. Endocrinol. 2009, 23:1657-1667.
74. Zubair M., Parker K.L., Morohashi K. Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing. Mol. Cell. Biol. 2008, 28:7030-7040.